Global Direct-to-consumer Disease Risk and Health Test Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Direct-to-consumer Disease Risk and Health Test Market Overview

• 1.1 Product Overview and Scope of Direct-to-consumer Disease Risk and Health Test
• 1.2 Classification of Direct-to-consumer Disease Risk and Health Test by Types
  • 1.2.1 Global Direct-to-consumer Disease Risk and Health Test Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Types in 2018
  • 1.2.3 Celiac Disease
  • 1.2.4 Parkinson Disease
  • 1.2.5 Alzheimer Disease
  • 1.2.6 Other
• 1.3 Global Direct-to-consumer Disease Risk and Health Test Market by Application
  • 1.3.1 Global Direct-to-consumer Disease Risk and Health Test Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Online
  • 1.3.3 Offline
• 1.4 Global Direct-to-consumer Disease Risk and Health Test Market by Regions
  • 1.4.1 Global Direct-to-consumer Disease Risk and Health Test Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Direct-to-consumer Disease Risk and Health Test Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Direct-to-consumer Disease Risk and Health Test Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Direct-to-consumer Disease Risk and Health Test Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Direct-to-consumer Disease Risk and Health Test Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Direct-to-consumer Disease Risk and Health Test Status and Prospect (2014-2024)
• 1.5 Global Market Size of Direct-to-consumer Disease Risk and Health Test (2014-2024)

2 Manufacturers Profiles

• 2.1 23andMe
  • 2.1.1 Business Overview
  • 2.1.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 23andMe Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 MyHeritage
  • 2.2.1 Business Overview
  • 2.2.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 MyHeritage Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 LabCorp
  • 2.3.1 Business Overview
  • 2.3.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 LabCorp Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Myriad Genetics
  • 2.4.1 Business Overview
  • 2.4.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Myriad Genetics Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Ancestry.com
  • 2.5.1 Business Overview
  • 2.5.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Ancestry.com Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Quest Diagnostics
  • 2.6.1 Business Overview
  • 2.6.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Gene By Gene
  • 2.7.1 Business Overview
  • 2.7.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Gene By Gene Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 DNA Diagnostics Center
  • 2.8.1 Business Overview
  • 2.8.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Invitae
  • 2.9.1 Business Overview
  • 2.9.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Invitae Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 IntelliGenetics
  • 2.10.1 Business Overview
  • 2.10.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 IntelliGenetics Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Ambry Genetics
  • 2.11.1 Business Overview
  • 2.11.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Ambry Genetics Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Living DNA
  • 2.12.1 Business Overview
  • 2.12.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Living DNA Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 EasyDNA
  • 2.13.1 Business Overview
  • 2.13.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 EasyDNA Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Pathway Genomics
  • 2.14.1 Business Overview
  • 2.14.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Pathway Genomics Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.15 Centrillion Technology
  • 2.15.1 Business Overview
  • 2.15.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.15.2.1 Product A
    • 2.15.2.2 Product B
  • 2.15.3 Centrillion Technology Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.16 Xcode
  • 2.16.1 Business Overview
  • 2.16.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.16.2.1 Product A
    • 2.16.2.2 Product B
  • 2.16.3 Xcode Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.17 Color Genomics
  • 2.17.1 Business Overview
  • 2.17.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.17.2.1 Product A
    • 2.17.2.2 Product B
  • 2.17.3 Color Genomics Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.18 Anglia DNA Services
  • 2.18.1 Business Overview
  • 2.18.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.18.2.1 Product A
    • 2.18.2.2 Product B
  • 2.18.3 Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.19 African Ancestry
  • 2.19.1 Business Overview
  • 2.19.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.19.2.1 Product A
    • 2.19.2.2 Product B
  • 2.19.3 African Ancestry Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.20 Canadian DNA Services
  • 2.20.1 Business Overview
  • 2.20.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.20.2.1 Product A
    • 2.20.2.2 Product B
  • 2.20.3 Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.21 DNA Family Check
  • 2.21.1 Business Overview
  • 2.2.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.21.2.1 Product A
    • 2.21.2.2 Product B
  • 2.21.3 DNA Family Check Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.22 Alpha Biolaboratories
  • 2.22.1 Business Overview
  • 2.22.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.22.2.1 Product A
    • 2.22.2.2 Product B
  • 2.22.3 Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.23 Test Me DNA
  • 2.23.1 Business Overview
  • 2.23.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.23.2.1 Product A
    • 2.23.2.2 Product B
  • 2.23.3 Test Me DNA Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.24 23 Mofang
  • 2.24.1 Business Overview
  • 2.24.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.24.2.1 Product A
    • 2.24.2.2 Product B
  • 2.24.3 23 Mofang Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.25 Genetic Health
  • 2.25.1 Business Overview
  • 2.25.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.25.2.1 Product A
    • 2.25.2.2 Product B
  • 2.25.3 Genetic Health Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.26 DNA Services of America
  • 2.26.1 Business Overview
  • 2.26.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.26.2.1 Product A
    • 2.26.2.2 Product B
  • 2.26.3 DNA Services of America Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.27 Shuwen Health Sciences
  • 2.27.1 Business Overview
  • 2.27.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.27.2.1 Product A
    • 2.27.2.2 Product B
  • 2.27.3 Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.28 Mapmygenome
  • 2.28.1 Business Overview
  • 2.28.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.28.2.1 Product A
    • 2.28.2.2 Product B
  • 2.28.3 Mapmygenome Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)
• 2.29 Full Genomes
  • 2.29.1 Business Overview
  • 2.29.2 Direct-to-consumer Disease Risk and Health Test Type and Applications
    • 2.29.2.1 Product A
    • 2.29.2.2 Product B
  • 2.29.3 Full Genomes Direct-to-consumer Disease Risk and Health Test Revenue, Gross Margin and Market Share (2017-2018)

3 Global Direct-to-consumer Disease Risk and Health Test Market Competition, by Players

• 3.1 Global Direct-to-consumer Disease Risk and Health Test Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Direct-to-consumer Disease Risk and Health Test Players Market Share
  • 3.2.2 Top 10 Direct-to-consumer Disease Risk and Health Test Players Market Share
• 3.3 Market Competition Trend

4 Global Direct-to-consumer Disease Risk and Health Test Market Size by Regions

• 4.1 Global Direct-to-consumer Disease Risk and Health Test Revenue and Market Share by Regions
• 4.2 North America Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
• 4.3 Europe Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
• 4.5 South America Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)

5 North America Direct-to-consumer Disease Risk and Health Test Revenue by Countries

• 5.1 North America Direct-to-consumer Disease Risk and Health Test Revenue by Countries (2014-2019)
• 5.2 USA Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
• 5.3 Canada Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)

6 Europe Direct-to-consumer Disease Risk and Health Test Revenue by Countries

• 6.1 Europe Direct-to-consumer Disease Risk and Health Test Revenue by Countries (2014-2019)
• 6.2 Germany Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
• 6.3 UK Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
• 6.4 France Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
• 6.5 Russia Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
• 6.6 Italy Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue by Countries

• 7.1 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue by Countries (2014-2019)
• 7.2 China Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
• 7.3 Japan Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
• 7.4 Korea Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
• 7.5 India Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)

8 South America Direct-to-consumer Disease Risk and Health Test Revenue by Countries

• 8.1 South America Direct-to-consumer Disease Risk and Health Test Revenue by Countries (2014-2019)
• 8.2 Brazil Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Direct-to-consumer Disease Risk and Health Test by Countries

• 9.1 Middle East and Africa Direct-to-consumer Disease Risk and Health Test Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
• 9.3 UAE Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Direct-to-consumer Disease Risk and Health Test Revenue and Growth Rate (2014-2019)

10 Global Direct-to-consumer Disease Risk and Health Test Market Segment by Type

• 10.1 Global Direct-to-consumer Disease Risk and Health Test Revenue and Market Share by Type (2014-2019)
• 10.2 Global Direct-to-consumer Disease Risk and Health Test Market Forecast by Type (2019-2024)
• 10.3 Celiac Disease Revenue Growth Rate (2014-2024)
• 10.4 Parkinson Disease Revenue Growth Rate (2014-2024)
• 10.5 Alzheimer Disease Revenue Growth Rate (2014-2024)
• 10.6 Other Revenue Growth Rate (2014-2024)

11 Global Direct-to-consumer Disease Risk and Health Test Market Segment by Application

• 11.1 Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Application (2014-2019)
• 11.2 Direct-to-consumer Disease Risk and Health Test Market Forecast by Application (2019-2024)
• 11.3 Online Revenue Growth (2014-2019)
• 11.4 Offline Revenue Growth (2014-2019)

12 Global Direct-to-consumer Disease Risk and Health Test Market Size Forecast (2019-2024)

• 12.1 Global Direct-to-consumer Disease Risk and Health Test Market Size Forecast (2019-2024)
• 12.2 Global Direct-to-consumer Disease Risk and Health Test Market Forecast by Regions (2019-2024)
• 12.3 North America Direct-to-consumer Disease Risk and Health Test Revenue Market Forecast (2019-2024)
• 12.4 Europe Direct-to-consumer Disease Risk and Health Test Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue Market Forecast (2019-2024)
• 12.6 South America Direct-to-consumer Disease Risk and Health Test Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Direct-to-consumer Disease Risk and Health Test Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology